MA15.07 Preliminary Analysis of Adjuvant Chemotherapy with Atezolizumab in Stage I-III Resected NSCLC and Clearance of ctDNA
Year: 2024
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: R. Maniar, E. Shum, N.A. Mohindra, D.H. Owen, P.C. Ma, M. Haigentz, R.D. Hall, S.A. Rajguru, J. Grindheim, K. Schulze, N.H. Hanna
Institutions: Indiana University Melvin and Bren Simon Comprehensive Cancer Center, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Penn State Cancer Institute, Rutgers Cancer Institute, University of Virginia Cancer Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Genentech
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4403420102